Prostate Cancer - Results from #23220

Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer? - Abstract June 10, 2013

Gross hematuria in patients with prostate cancer: Etiology and management - Abstract June 10, 2013

Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions - Abstract June 10, 2013

Ultrasonography in prostate cancer: Current roles and potential applications in radiorecurrent disease - Abstract June 10, 2013

Correlation between the complex PSA/total PSA ratio and the free PSA/total PSA ratio, sensitivity and specificity of both markers for the diagnosis of prostate cancer - Abstract June 10, 2013

Probabilistic objective functions for margin-less IMRT planning - Abstract June 10, 2013

New treatment options for castration-resistant prostate cancer - Abstract June 10, 2013

A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: An example application to prostate cancer planning - Abstract June 8, 2013

Treatment of bladder outlet obstruction in locally advanced prostate cancer - Abstract June 8, 2013

Treatment of prostate cancer with intermittent versus continuous androgen deprivation: A systematic review of randomized trials - Abstract June 8, 2013

Managing urine leakage following laparoscopic radical prostatectomy with active suction of the prevesical space - Abstract June 8, 2013

Prostate cancer magnetic resonance imaging (MRI): Multidisciplinary standpoint - Abstract June 8, 2013

Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy - Abstract June 8, 2013

Choline PET/CT for imaging prostate cancer: An update - Abstract June 7, 2013

Statin use in relation to prostate cancer outcomes in a population-based patient cohort study - Abstract June 7, 2013

Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity - Abstract June 7, 2013

Socioeconomic advantages of longer screening intervals for men with low prostate-specific antigen levels in prostate cancer mass screening - Abstract June 7, 2013

Radiation therapy for prostate cancer - Abstract June 6, 2013

A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer - Abstract June 6, 2013

Life expectancy estimates as a key factor in over-treatment: The case of prostate cancer - Abstract June 6, 2013

Page 1162 of 1447